Affiliation:
1. Medical Center “21st Century”
Abstract
Premenstrual syndrome (PMS) is a common neuroendocrine pathology. PMS has a significant impact on the women’s lives. It negatively affects the psychophysiological state, social functioning, reduces ability to work and quality of life. Therefore, it has great medical and social significance. According to numerous studies, PMS prevalence ranges from 25 % to 80 %. PMS clinical picture is characterized by a variety of mental and somatic symptoms of varying severity, that leads to certain difficulties in choosing therapy. Currently, there are no clinical guidelines for the diagnosis and treatment of this pathology in Russia. The task of practitioners is to find the most effective, safe and pathogenetically justified treatment modes, based on an individual approach depending on the clinical manifestations of the disease.
The review presents the results of various PMS treatment modalities, presented in eLibrary.ru, Pubmed, SpringerLink, APA PsycNET, ScienceDirect, and Google Scholar. Current experience shows that PMS therapy should be carried out comprehensively. In order to achieve and maintain good results, it is advisable to combine drug therapy with cognitive behavioral therapy, physical therapy and physiotherapy.
PMS is an interdisciplinary problem, so it should be treated by various specialists. It is important to differentiate between PMS, somatic pathology and affective states. A large scope of treatment modalities does not exclude the patients who do not respond to therapy. It proves the need for further study of the disease pathogenesis and the development of preventive measures with respect to modern medical advances.
Publisher
Ulyanovsk State University
Reference68 articles.
1. Nevatte T., O'Brien P.M., Bäckström T., Brown C., Dennerstein L., Endicott J., Epperson C.N., Eriksson E., Freeman E.W., Halbreich U., Yonkers K. Consensus Group of the International Society for Premenstrual Disorders. ISPMD consensus on the management of premenstrual disorders. Arch. Womens. Ment. Health. 2013; 4: 279–291. DOI: 10.1007/s00737-013-0346-y.
2. Ismaili E., Walsh S., O'Brien P.M.S., Bäckström T., Brown C., Dennerstein L., Eriksson E., Freeman E.W., Ismail K.M.K., Panay N., Yonkers K. Consensus Group of the International Society for Premenstrual Disorders. Fourth consensus of the International Society for Premenstrual Disorders (ISPMD): auditable standards for diagnosis and management of premenstrual disorder. Arch. Womens. Ment. Health. 2016; 19 (6): 953–958. DOI: 10.1007/s00737-016-0631-7.
3. Geta T.G., Woldeamanuel G.G., Dassa T.T. Prevalence and associated factors of premenstrual syndrome among women of the reproductive age group in Ethiopia: Systematic review and meta-analysis. PLoS. One. 2020; 15 (11): e0241702. DOI: 10.1371/journal.pone.0241702.
4. Belokrinitskaya T.E., Frolova N.I., Belozertseva E.P. Dismenoreya, predmenstrual'nyy sindrom i sindrom predmenstrual'nogo disforicheskogo rasstroystva u devushek-studentok [Dysmenorrhea, premenstrual syndrome and premenstrual dysphoric disorder syndrome in female students]. Reproduktivnoe zdorov'e detey i podrostkov. 2012; 1: 22–28 (in Russian).
5. Yoshimi K., Matsumura N., Takeda T. When and how do adolescent girls in Japan become aware of premenstrual symptoms from menarche? A cross-sectional study among senior high school students. BMJ Open. 2021; 11 (8): e045215. DOI: 10.1136/bmjopen-2020-045215.